BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34578268)

  • 1. Prevalence of Nasal Shedding of Equid Gammaherpesviruses in Healthy Swiss Horses.
    Scheurer L; Bachofen C; Hardmeier I; Lechmann J; Schoster A
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR.
    Ataseven VS; Dağalp SB; Güzel M; Başaran Z; Tan MT; Geraghty B
    Res Vet Sci; 2009 Apr; 86(2):339-44. PubMed ID: 18649902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
    Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
    J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of a quantitative PCR assay to study equine herpesvirus 5 invasion and replication in equine tissues in vitro and in vivo.
    Zarski LM; High EA; Nelli RK; Bolin SR; Williams KJ; Hussey G
    J Virol Methods; 2017 Oct; 248():44-53. PubMed ID: 28455133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of shedding of respiratory pathogens in horses recently imported to the United States.
    Smith FL; Watson JL; Spier SJ; Kilcoyne I; Mapes S; Sonder C; Pusterla N
    J Vet Intern Med; 2018 Jul; 32(4):1436-1441. PubMed ID: 29761571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Perkins G; Babasyan S; Stout AE; Freer H; Rollins A; Wimer CL; Wagner B
    Virology; 2019 May; 531():219-232. PubMed ID: 30928700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantification of equine herpesvirus-1 viremia and nasal shedding by real-time polymerase chain reaction.
    Hussey SB; Clark R; Lunn KF; Breathnach C; Soboll G; Whalley JM; Lunn DP
    J Vet Diagn Invest; 2006 Jul; 18(4):335-42. PubMed ID: 16921871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Equid gammaherpesvirus 2 and 5 DNA in the upper respiratory tract of asymptomatic horses from Southern Brazil.
    Dall Agnol AM; Beuttemmuller EA; Pilz D; Leme RA; Saporiti V; Headley SA; Alfieri AF; Alfieri AA
    Braz J Microbiol; 2019 Jul; 50(3):875-878. PubMed ID: 31187445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological and serological investigation of Equid herpesvirus 1 infection in New Zealand.
    Dunowska M; Gopakumar G; Perrott MR; Kendall AT; Waropastrakul S; Hartley CA; Carslake HB
    Vet Microbiol; 2015 Apr; 176(3-4):219-28. PubMed ID: 25666453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of latent Equid herpesviruses in the tissues of 40 abattoir horses.
    Edington N; Welch HM; Griffiths L
    Equine Vet J; 1994 Mar; 26(2):140-2. PubMed ID: 8575377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four methods to quantify Equid herpesvirus 1 load by real-time polymerase chain reaction in nasal secretions of experimentally and naturally infected horses.
    Pusterla N; Hussey SB; Mapes S; Leutenegger CM; Madigan JE; Ferraro GL; Wilson WD; Lunn DP
    J Vet Diagn Invest; 2009 Nov; 21(6):836-40. PubMed ID: 19901285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies.
    Eady NA; Holmes C; Schnabel C; Babasyan S; Wagner B
    J Virol; 2024 Jun; 98(6):e0025024. PubMed ID: 38742875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of equid herpesvirus-1 reactivation and viremia in hospitalized critically ill horses.
    Carr E; Schott H; Pusterla N
    J Vet Intern Med; 2011; 25(5):1190-3. PubMed ID: 21848945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and quantitation of equid gammaherpesviruses (EHV-2, EHV-5) in nasal swabs using an accredited standardised quantitative PCR method.
    Hue ES; Fortier GD; Fortier CI; Leon AM; Richard EA; Legrand LJ; Pronost SL
    J Virol Methods; 2014 Mar; 198():18-25. PubMed ID: 24370678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and sequence analysis of equid herpesviruses from the respiratory tract of Polish horses.
    Stasiak K; Dunowska M; Rola J
    Virol J; 2018 Jul; 15(1):106. PubMed ID: 29996858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of equine gammaherpesviruses on breeding farms in Turkey and development of a TaqMan MGB real-time PCR to detect equine herpesvirus 5 (EHV-5).
    Akkutay AZ; Osterrieder N; Damiani A; Tischer BK; Borchers K; Alkan F
    Arch Virol; 2014 Nov; 159(11):2989-95. PubMed ID: 25008897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.
    Bell SA; Balasuriya UB; Gardner IA; Barry PA; Wilson WD; Ferraro GL; MacLachlan NJ
    Vet Microbiol; 2006 Sep; 116(4):249-57. PubMed ID: 16774810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
    BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.